Reduced CD38 expression on CD34 + cells as a diagnostic test in myelodysplastic syndromes

Haematologica

Volumn 94, Issue 8, 2009, Pages 1160-1163

  Goardon, Nicolas ^a   Nikolousis, Emmanouil ^b   Sternberg, Alexander ^a,b,c   Chu, Wai Kit ^a   Craddock, Charles ^b   Richardson, Peter ^f   Benson, Richard ^d   Drayson, Mark ^f   Standen, Graham ^e   Vyas, Paresh ^a   Freeman, Sylvie ^b,f  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c GREAT WESTERN HOSPITAL   (United Kingdom)

^d NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^e BRISTOL ROYAL INFIRMARY   (United Kingdom)

^f UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

FACS diagnosis; Immunophenotype; Myelodyplasia

Indexed keywords

CD38 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; CYTOPENIA; DIAGNOSTIC TEST; FLOW CYTOMETRY; HEMATOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAXIMUM ALLOWABLE CONCENTRATION; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIGENS, CD34; ANTIGENS, CD38; BONE MARROW CELLS; FLOW CYTOMETRY; HUMANS; MYELODYSPLASTIC SYNDROMES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 68049124954     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2008.004085     Document Type: Article

References (16)

1. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999;340:1649-60.
2. Nimer SD. Myelodysplastic syndromes. Blood 2008;111:4841-51.
3. Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001;98:979-87.
4. Del Canizo MC, Fernandez ME, Lopez A, Vidriales B, Villaron E, Arroyo JL, et al. Immunophenotypic analysis of myelodysplastic syndromes. Haematologica 2003;88: 402-7.
5. Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003;102:394-403.
6. Sternberg A, Killick S, Littlewood T, Hatton C, Peniket A, Seidl T, et al. Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood 2005;106: 2982-91.
7. Della Porta MG, Malcovati L, Invernizzi R, Travaglino E, Pascutto C, Maffioli M, et al. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 2006;20:549-55.
8. Monreal MB, Pardo ML, Pavlovsky MA, Fernandez I, Corrado CS, Giere I, et al. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia. Cytometry B Clin Cytom 2006;70:63-70.
9. Ogata K, Kishikawa Y, Satoh C, Tamura H, Dan K, Hayashi A. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 2006;108:1037-44.
10. Lorand-Metze I, Ribeiro E, Lima CS, Batista LS, Metze K. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with nonclonal disorders. Leuk Res 2007;31:147-55.
11. van de Loosdrecht AA, Westers TM, Westra AH, Drager AM, van der Velden VH, Ossenkoppele GJ. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood 2008;111:1067-77.
12. Matarraz S, Lopez A, Barrena S, Fernandez C, Jensen E, Flores J, et al. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors. Leukemia 2008;22:1175-83.
13. Satoh C, Dan K, Yamashita T, Jo R, Tamura H, Ogata K. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes. Leuk Res 2008;32:699-707.
14. Ribeiro E, Matarraz Sudon S, de Santiago M, Lima CS, Metze K, Giralt M, et al. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes. Leuk Res 2006;30:9-16.
15. Maftoun-Banankhah S, Maleki A, Karandikar NJ, Arbini AA, Fuda FS, Wang HY, et al. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes. Am J Clin Pathol 2008;129: 300-8.
16. Edvardsson L, Dykes J, Olofsson T. Isolation and characterization of human myeloid progenitor populations - TpoR as discriminator between common myeloid and megakaryocyte/erythroid progenitors. Exp Hematol 2006;34:599-609.